Drug intelligence / Profile preview

Bu Shen Yi Jing Pill

Development stage: Phase 2
Lead developer: KK Women's and Children's Hospital
Administration: Oral

Overview

Bu Shen Yi Jing (BSYJ) Pill is a Traditional Chinese Medicine (TCM) formulation primarily used to address male subfertility and improve semen quality. Based on TCM principles, the formula is designed to tonify the Kidney and replenish Essence (Jing), which are considered vital for reproductive health. The pill is typically composed of a complex mixture of herbs, which may include Rehmannia glutinosa, Lycium barbarum, and other botanical ingredients known for their antioxidant and endocrine-modulating properties. It has been evaluated in clinical trials, notably by KK Women's and Children's Hospital in Singapore, to assess its efficacy in improving sperm concentration, motility, and morphology in subfertile males with Kidney Deficiency.

Other names: Bu Shen Yi Jing WanBSYJ

Beyond the preview

Go deeper on Bu Shen Yi Jing Pill.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Bu Shen Yi Jing Pill.

Explore the full profile